Menu
Account
Settings
Cinfalair 10 mg 28 Film-Coated Tablets

Cinfalair 10 mg 28 Film-Coated Tablets

Special Price KWD 9.79
In stock
SKU
10148
Add to Compare
Quick Overview

Your ambition for long-term respiratory stabilization and the biological prevention of asthma-induced bronchoconstriction is achieved with this high-potency leukotriene receptor antagonist. Cinfalair 10mg (Montelukast) optimizes your pulmonary function by blocking specific inflammatory mediators, ensuring an authenticated approach to chronic respiratory management.

1 - The Expert's Seal: Why Ora Selected This?

"Reviewed by Pharmacist Nora: Selected for its high potency and its specialized 'steroid-free' anti-inflammatory mechanism. This is a medical essential because it specifically targets cysteinyl leukotrienes, which are biological triggers for airway swelling and mucus buildup. We chose this for the Cinfa portfolio (Spain) because it offers a high-performance alternative or supplement to inhaler therapy. It serves as a gold standard for managing exercise-induced asthma and seasonal allergic rhinitis in Kuwait, providing 24-hour protection with a single oral dose."

2 - The Ora Standard: Authenticity & Velocity

Your health aura starts with authenticity, and we safeguard your investment through rigorous pharmaceutical standards:

  • Global Sourcing: Direct from authorized Laboratorios Cinfa Spain distributors, establishing the new standard for verified European pharmaceutical origins.

  • Climate-Controlled Storage: Medical-grade preservation ensures that the Montelukast sodium molecules remain stable and bioactive—critical for chronic maintenance therapy.

  • Rapid Delivery: Skip the wait; choose Ora speed for doorstep delivery across Kuwait within hours—ensuring your respiratory therapy cycle remains uninterrupted.

3 - Technical Specs: Active Ingredients

  • Montelukast 10mg: A pharmaceutical-grade selective leukotriene receptor antagonist that biologically inhibits the CysLT1 receptor.

  • Mechanism of Action: Blocks the action of leukotriene D4, which is significantly more potent than histamine in causing airway constriction and inflammation.

  • Pharmacokinetics: Formulated for rapid absorption, typically reaching peak plasma concentration within 3 hours of administration.

  • Dual-Action Relief: Clinically indicated for the chronic treatment of asthma and the symptomatic relief of seasonal and perennial allergic rhinitis.

Elevate Your Health Now

Secure your authentic supply of Cinfalair 10mg now. An investment in high-precision respiratory control is an investment in your daily freedom of movement. Delivered rapidly across Kuwait.

To transform this medication into a high-performance tool for asthma management, integrate these precise steps into your regimen:

  • The "Nocturnal-Anchor" Protocol: For asthma management, take your tablet in the evening. This is a clinical requirement to counteract the biological dip in lung function that typically occurs during the early morning hours.

  • The "Maintenance-Mandate": Cinfalair is not a rescue medication. For surgical-grade results, you must take it every day even when you have no symptoms. It biologically builds a "shield" over time.

  • The "Allergy-Timing" Rule: If you are using this primarily for allergic rhinitis, the timing is flexible, but consistency remains the medical key to preventing systemic inflammatory flares.

  • The "Bio-Monitoring" Mandate: This medication must be used under the supervision of a physician. While rare, it is a clinical recommendation to monitor for mood or behavioral changes.